Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. November 2024 21:02 ET | Quelle: Robbins LLP

EVLV STOCK NEWS: Robbins LLP Encourages Evolv Technologies Holdings, Inc. Stockholders with Significant Losses to Seek Counsel for the EVLV Class Action

Robbins LLP is Investigating Allegations that Evolv Technologies Holdings, Inc. (EVLV) Misled Investors Regarding Revenue Recognition
05. November 2024 15:27 ET | Quelle: Robbins LLP

EVLV Stockholder Alert: Robbins LLP Reminds Investors of the Evolv Technologies Holdings, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Evolv Technologies Holdings, Inc. (EVLV) Misled Investors Regarding Revenue Recognition
09. Mai 2024 15:17 ET | Quelle: Robbins LLP

Stockholder Alert: Robbins LLP Reminds EVLV Stockholders of Upcoming May 24, 2024 Lead Plaintiff Deadline in the Evolv Technologies Holdings, Inc. Class Action

Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
15. April 2024 16:51 ET | Quelle: Robbins LLP

EVLV Stockholders Should Contact Robbins LLP for Information about the Evolv Technologies Holdings, Inc. Class Action

Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
05. April 2024 13:27 ET | Quelle: Robbins LLP

EVLV Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Evolv Technologies Holdings, Inc. Class Action

Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
26. März 2024 15:56 ET | Quelle: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Evolv Technologies Holdings, Inc. f/k/a Newhold Investment Corp.

Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products